Loading...
Chemical structure of CHDI 00484077

GC26829

CHDI 00484077

Also known as N-[(2R)-1-[(2S)-2-methylpyrrolidin-1-yl]propan-2-yl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide

CHDI 00484077 is a highly selective, central nervous system (CNS) permeable Class IIa HDAC inhibitor with inhibitory effects on HDAC4, HDAC5, HDAC7, and HDAC9, which improves neuronal function, and can be used to study Huntington's disease

ChemicalCAS3025894-92-9MW382.38FormulaC18H21F3N4O2
CAS number
3025894-92-9
Molecular weight
382.38
Formula
C18H21F3N4O2
InChIKey
DBWSFWPXCPNWRZ-NEPJUHHUSA-N
Catalogue number
GC26829
Brand
GLPBIO
Computed properties PubChem CID 162675553 · XLogP 3.4 · TPSA 71.3 Ų · H-bond donors 1
XLogP
3.4
TPSA
71.3 Ų
H-bond donors
1
H-bond acceptors
8
Rotatable bonds
5
Heavy atoms
27

SMILES C[C@H]1CCCN1C[C@@H](C)NC(=O)C2=CC=C(C=C2)C3=NOC(=N3)C(F)(F)F

Computed descriptors from PubChem (CID 162675553), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.